#Transdermal Drug Delivery Business Focus | Explore Tumblr Posts and Blogs

jayanthitbrc · 4 months

Text

Sustained Release Excipients Market Growth And Demand Forecast 2024-2033: Salix Pharmaceuticals, Allergan PLC, AstraZeneca

The Sustained Release Excipients Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033). Learn More On The Sustained Release Excipients Market: https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report According to The Business Research Company’s Sustained Release Excipients Global Market Report 2024, The sustained release excipients market size has grown strongly in recent years. It will grow from $1.29 billion in 2023 to $1.41 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The sustained release excipients market size is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing geriatric population, focus on personalized medicine, challenges in patient adherence, rise in complex drug formulations, advancements in disease management, global healthcare expansion. The increasing prevalence of chronic and acute diseases is expected to propel the growth of the sustained-release excipients market going forward. Chronic and acute diseases are two distinct categories used to classify different illnesses based on their duration and progression. Chronic diseases are long-lasting medical conditions that persist over an extended period, typically three months or more. Acute diseases are characterized by a rapid onset of symptoms that are usually severe but short-lived. These diseases develop suddenly and generally last briefly, ranging from hours to days or weeks. Sustained-release excipients are widely used to formulate pharmaceutical products for both chronic and acute diseases. It improves patient adherence, maintains consistent drug levels, reduces side effects, and improves disease management, so these factors boost the sales of sustained-release excipients. Get A Free Sample Of The Report (Includes Graphs And Tables): https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp The sustained release excipients market covered in this report is segmented – 1) By Product: Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan 2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration 3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation Product innovation is the key trend gaining popularity in the sustained release excipients market. Major companies operating in the sustained release excipients market are developing innovative products to strengthen their position in the market. The sustained release excipients market report table of contents includes: 1. Executive Summary 2. Market Characteristics 3. Market Trends And Strategies 4. Impact Of COVID-19 5. Market Size And Growth 6. Segmentation 7. Regional And Country Analysis . . . 27. Competitive Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: [email protected] Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

0 notes

researchvishal · 2 years

Text

Peptide Therapeutics Market SWOT Analysis, Dynamics, Drivers, Key Indicators and Forecast to 2025

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI), the worldwide peptide therapeutics market share currently valued at US$ 34.4 billion, is anticipated to grow at a remarkable CAGR of 11% from 2022 to 2025, reaching US$ 47 billion.

Peptide therapeutics demand are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such as cancer, cardiovascular diseases, hematologic diseases, and gastro-intestinal diseases.

Rising prevalence of these chronic diseases across the world is further expected to widen the existing patient pool. Therapeutic efficacy of peptide therapeutics is relatively superior as compared to other marketed drugs, resulting in their higher adoption among physicians.

The global peptide therapeutics market was valued at US$ 25.6 Bn in 2021, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2022-2025).

The COVID-19 pandemic has been severely affecting the global economic order, and, in turn, the peptide therapeutics market. Restrictions on traveling, self-quarantines, and social distancing regulations, on a national scale, are resulting in notable drop in business and consumer spending through Q2.

Key Takeaways of Peptide Therapeutics Market Study

In terms revenue generation, among the applications, cancer outperformed other application types, owing to greater prevalence of the disease as well as higher efficacy of peptide therapeutics in cancer treatment.

Various peptide therapeutics are patented, and, in the mid of this decade, a majority of these patents are expected to reach their expiry dates, leading to higher generic competition.

Parenteral route continues to hold the leading revenue share in the peptide therapeutics market, owing to effective drug delivery and higher therapeutic index.

Key Players Focus on Strategic Collaborations and Generic Launches to Widen Regional Presence

Top peptide therapeutics companies are:

Eli Lilly and Company AstraZeneca plc Merck & Co. Inc Ipsen S.A Novo Nordisk A/S Teva Pharmaceutical Industries Ltd.

are concentrating on business expansions through joint ventures and distribution agreements, and are capturing untapped market potential.

Additionally, market incumbents are entering into collaborations in order to expand their regional presence and manufacturing capabilities in the global peptide therapeutics market.

More Valuable Insights on Peptide Therapeutics Market

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the segments from 2014 to 2025. The global peptide therapeutics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

For more Information @ https://www.futuremarketinsights.com/reports/peptide-therapeutics-market

The study provides compelling insights on the peptide therapeutics market on the basis of application, (cancer, cardiovascular diseases, central nervous systems, metabolic disorders, infection, hematological disorders, gastrointestinal disorders, dermatology, respiratory disorders, acromegaly, and other applications), route of administration (parenteral route, mucosal route, oral route, and transdermal route), and marketing (branded and generic), across seven major regions.

Key Segments Of Peptide Therapeutics Market Industry Survey

By Application :

Cancer

Cardiovascular Diseases

Central Nervous Systems

Metabolic Disorders

Infections

Hematological Disorders

Gastrointestinal Disorders

Dermatology

Respiratory Disorders

Acromegaly

Other Applications

By Route of Administration :

Parenteral Route of Administration

Mucosal Route of Administration

Oral Route of Administration

Transdermal of Route Administration

By Drug Type :

Branded Drugs

Generic/Biosimilar Drugs

0 notes

abbviecontractmfg · 2 years

Text

A Quick Evaluation of the Hot Melt Extrusion Process

Hot melt extrusion (HME) is the technique of heating polymeric materials far beyond their glass transition temperature (abbreviated Tg in pharmaceutical production circles) to achieve molecular level mixing of active compounds, polymers, and thermoplastic binders. HME is a mix of mechanical and melting energy that is used in a variety of sectors to improve continuous processing for dust reduction, online monitoring, and reproducible material analysis.

HME services are applied in pharmaceutical production to diffuse APIs in a matrix at the molecular level for the purpose of getting solid solutions. This allows for the development of drug delivery methods for poorly soluble medicines or specialty drug forms such as antidiabetic drugs and transdermal patch films.

Today, hot melt extrusion has an exalted position in pharmaceutical production and is used to make a variety of medication forms such as implants, granules, pellets, prolonged release tablets, and ophthalmic inserts. Polymers may be molded into a film by hot melt extrusion, eliminating the need for traditional solvent-casting procedures.

The pharmaceutical industry's focus on hot melt extrusion is primarily on the creation of bio-enhanced formulations, mass production of medications in the form of pellets, beads, and transdermal systems, and the formation of solid solutions from water soluble pharmaceuticals. This highlights hot melt extrusion as having advantages over more typical drug production procedures, but not without some cons.

Pros and Cons of HME Services

When it comes to pharmaceutical manufacturing, hot melt extrusion has several benefits over traditional drug manufacturing methods. Below are these pros and cons:

Pros

There are fewer procedures involved, along with the elimination of drying steps, which boosts productivity and saves time. The procedure is straightforward and may be carried out uninterruptedly and efficiently.

Because of the high temperatures and powerful mixing that ensue during the production process, active chemicals are more uniformly distributed in the polymer, resulting in higher bioavailability.

Hot melt extrusion allows for the production of a broad range of dosage forms, which is one of the main reasons why contract manufacturing pharma businesses are adopting the method on a larger scale.

When compared to traditional processes, the advantages clearly make this method of production enticing, but it is not without its problems.

Cons

Because it is a thermic process, there may be problems with the API/polymer stability. The flow characteristics of the polymer are critical in effective processing, and heat manufacturing can occasionally be a concern during the process.

The required number of polymers may be limited due to the fact that getting polymers that can be treated at low temperatures for this process can be difficult.

Looking For Quality Contract Pharma Services? AbbVie is here to meet those needs

AbbVie is a contract pharmaceutical manufacturer specializing in controlled release technologies such as fluid bed processing and hot melt extrusion (HME).

AbbVie Contract Manufacturing advances your science with proprietary hot melt extrusion technology and services.

AbbVie offers different kinds of customized and proprietary hot melt extrusion services such as:

• End-to-end manufacturing from extrudate to packaged drug product.

• Expertise in bioavailability enhancement

• Solvent-free and continuous processing

• Support for good process control and scalability

• Abuse deterrent and taste masking capabilities.

Learn more about our processes here.

#hme services #proprietary hot melt extrusion #hot melt extrusion #proprietary hot melt

0 notes

enchantingvoid · 2 years

Text

Drug and Gene Delivery Devices Market Analysis Geography Trends, Demand and Forecasts 2030

Global Drug and Gene Delivery Devices Market: Snapshot

The world drug and gene delivery devices market is projected to be strengthened by the efforts taken to widen the bioavailability of drugs at target sites and improve patient convenience while formulating dosage forms. The drug and gene delivery devices industry could gain a bolstered growth in demand on the back of the advent of subdermal implants and other advanced drug delivery systems available in various arrangements such as patches and rings. The fruition of drug delivery systems could be credited to altering preferences by both healthcare professionals and patients.

Download PDF Brochure: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1256

Some of the prominent advancements in the world drug and gene delivery devices market include the emergence of novel pulmonary instruments such as adaptive aerosol delivery (AAD) and Smartcard. The accessibility to sophisticated implants in customized sizes and shapes, inception of auto-injectors, and advent of biopharmaceutical classification systems (BCS) class II drug in oral dosage forms are anticipated to be other factors contributing toward the growth of drug and gene delivery devices.

According to an insight of the world drug and gene delivery devices market, ‘in situ’ could account for a larger share since most drugs currently approved are studied to act by the method. In situ is prophesied to be a faster growing market for drug and gene delivery devices because of the factor of performance ease. Another market, viral vector, could bring in ample of opportunities in the drug and gene delivery devices industry. This is estimated to take shape due to an over 60.0% of ongoing clinical gene therapy trials being dependent on viral vectors for transfection.

Global Drug and Gene Delivery Devices Market: Overview

The changing preferences of physicians and patients in administration of medicines has been the primary growth driver for the global drug and gene delivery devices market. The increasing efforts to minimize the incidences of bacterial diseases, viral diseases, and developing novel ways of managing health conditions such as diabetes are have been the powerful factors determining the trajectory of the global market. Over the years, the global market has also benefited by the tremendous growth in gene therapy that has introduced treatment for a wide range of diseases. The global market is being driven by the introduction of auto-injectors, adoption of advanced implants, and development of advanced devices that have revolutionized drug and gene delivery.

The detailed study includes an unbiased and deliberate take on the market dynamics and the various factors deciding its trajectory. The report is a tool for every reader and business enthusiast for making well-informed choices.

Global Drug and Gene Delivery Devices Market: Trends and Drivers

The various routes of administration available in the global market are ocular, injectable, transdermal, nasal, topical, oral, and inhalation. Of these, the oral segment held the largest share in the global market and is anticipated to continue its stance in the coming years. The ease and convenience of packing a prescribed dosage in an oral medication in the key growth driver for this segment. In the coming years, players are expected to focus on potency, safety, and quality of biotechnology agents.

A rising pool of geriatrics, increasing number of diabetics, and technological advancements have also had a positive impact on the global market in recent years. The remarkable improvements in the healthcare infrastructure in developing economies has also been critical to the soaring earnings of the global drug and gene delivery devices market.

Global Drug and Gene Delivery Devices Market: Regional Outlook

Geographically, the global drug and gene delivery devices market is spread over Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. The report indicates that North America held a significant share in the global market and is expected show its dominance in the coming years. The well-established healthcare infrastructure, excellent funds for research and development activities pertaining to drug and gene delivery devices in the U.S., and increasing rate of diagnoses and awareness amongst patients are the pillars of the North America market. The strong foothold of North America drug and gene delivery devices market will also be attributable to the adoption of technology in the region.

The report also points out that Asia Pacific will be the next big regional market in the overall market. The rise of Asia Pacific drug and gene delivery devices market will be due to the presence of several foreign players in the region, the emergence of medical tourism industry, and vast untapped market.

Key Players Mentioned in the Report are:

The important players leading the way are Johnson and Johnson Private Ltd, F. Hoffmann-La Roche Ltd, Bayer AG, Novartis AG, Becton, Dickinson and Company, and Pfizer, Inc. Most of these companies are making significant investments to develop improved products in order to meet the ever-changing needs of the patients.

About Us:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Rohit Bhisey

Head Internet Marketing

Tel: +1-415-520-1050

Website: https://www.tmrresearch.com/

0 notes

researchupdates · 3 years

Text

Global Microneedle Drug Delivery Systems Market Growth Statistics to Make Multi-Billion Dollar Market during 2021-2028

Global Microneedle Drug Delivery Systems Market Synopsis:

DBMR team offers customization of Microneedle Drug Delivery Systems Market report according to the business needs. Contact sales team, who will guarantee to get a report that suits the necessities. The Market analysis and competitor analysis helps the firm in determining the range in terms of sizes, colors, designs, and prices, etc. within which its products are to be offered to the consumers. Microneedle Drug Delivery Systems Market survey report offers strategic and tactical support to clients for making well-informed business decisions. It is an organized method to bring together and document information about the Healthcare industry, Market, or potential customers.

The info covered in the universal Microneedle Drug Delivery Systems Market document helps businesses know how patents, licensing agreements and other legal restrictions affect the manufacture and sale of the firm’s products. It is helpful in determining the discount rates, the actual prices and the price ranges, price elasticity for its products. Such report is made available for industries, individuals, and organizations across the globe, and offerings are delivered in the shortest possible turnaround time. The report carefully examines the global Microneedle Drug Delivery Systems Market, with a focus on most of the major players and their business strategies, geographical scope, Market segments, product landscape and price, and cost structure.

Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-microneedle-drug-delivery-systems-market .

The Global Microneedle Drug Delivery Systems Market is growing at a CAGR of 7.10% in the forecast period of 2020 to 2027.

According to the market report analysis, Microneedles are tiny needles, small enough to be weighted millionths of a meter, designed to supply medicines which has many advantages for biological agents compared with conventional needle and syringe delivery systems. Microneedle delivery of drugs plays a significant role in the pharmaceutical, biotechnology and medical industries and is used in applications such as neurology, dermatology, cardiovascular, oncology and others.

Some of most important key factors driving the growth of the Global Microneedle Drug Delivery Systems Market are increasing demand for safer substitute to conventional hypodermic injections, increasing technologies such as microneedle patches, rising interest in alternate routes of drug administration transdermal and intradermal drug delivery systems, early phase disease diagnosis and treatment, rapidly growing population.

The major players covered in the Microneedle Drug Delivery Systems Market report are 3M, nanoBioSciences, LLC, NanoPass, Microdermics, Zosano Pharma Corp, Micropoint Technologies, MyLife Technologies, Innoture Medical Technology Limited, Phillips-Medisize - a Molex Company, Corium Inc, Stemedica Cell Technologies, Inc, and LTS Lohmann Therapie-Systeme AG among other domestic and global players.

Regionally, North America dominates the microneedle drug delivery systems market because of growing awareness among patients and rapidly growing population while APAC is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to changing lifestyle of people and rising per capita expenditure.

Access Complete Report @ https://www.databridgemarketresearch.com/reports/global-microneedle-drug-delivery-systems-market .

#Microneedle Drug Delivery Systems #3M #NanoPass #Microdermics #Zosano Pharma #MyLife Tech #Corium

0 notes

nitasonwane · 3 years

Text

Thin Film Drugs Market Growth, Top Key Players, Trend, Opportunities Forecast to 2027

The global thin film drugs market size is projected to reach USD 16.27 billion in 2028. Fortune Business Insights™ published this information in a new study, titled, “Thin Film Drugs Market, 2021-2028.” The study further mentions that the market stood at USD 7.35 billion in 2020. It is expected to showcase a CAGR of 10.5% in the forecast period between 2021-2028. The surging geriatric population across the globe is anticipated to affect growth positively. As per the United Nations, in 2017, the global old age population was 962 million. It is estimated to double by the end of 2050 and reach 2.1 billion. Hence, the prevalence of Alzheimer’s and Parkinson’s diseases will also increase rapidly, thereby accelerating the demand for thin film drugs.

please visit: https://www.fortunebusinessinsights.com/thin-film-drugs-market-104883

Rising Focus on Developing COVID-19 Vaccine to Impact Growth Negatively

Several pharmaceutical companies are currently focusing on inventing a vaccine that would fight against the COVID-19 pandemic. It has resulted in disruptions of research and development activities associated with thin film drugs in various parts of the world. It is expected to hamper growth of the market in the near future. Our research reports will help you find the best strategy to uplift your businesses amid this pandemic.

Retail Pharmacy Segment to Dominate Backed by Easy Availability of Drugs

Our analysts have segmented the market on the basis of product, disease indication, distribution channels, and geography. By product, it is fragmented into transdermal film drugs and oral thin film (OTF) drugs. Based on the disease indication, it is divided into opioid dependence, migraine, schizophrenia, and others. Below is a glimpse of the distribution channel criterion:

By Distribution Channels: it is segregated into hospital pharmacy, retail pharmacy, and others. Amongst these, the retail pharmacy segment dominated in 2020 by earning the largest thin film drugs market share. This growth is attributable to the easy availability of thin film drug delivery models in retail pharmacies because of their possession of generic molecules.

Development of Cannabis-based Drugs to Propel Growth

The rising technological advancements occurring in the field of drug delivery systems is set to spur the thin film drugs market growth in the upcoming years. Additionally, numerous start-up firms are investing in the development of cannabis-based drugs. XPhyto Pharma, for instance, is likely to create around 13 drugs by using the thin firm drug delivery method. In Europe, the study is in Phase II clinical trial as of February 2021. However, the lack of high investments in emerging economies may obstruct growth.

0 notes

lucyj2223 · 3 years

Text

Global Topical Drug Delivery Market Business Analysis, Future Trend & Global Research Report

Global Topical Drug Delivery Market

Topical drug delivery is defined as the delivery of drugs through topical route like skin, mucus membrane or cavities in the body. These are applied topically the body. These drugs are applied locally to avoid the first-pass effect of the drug or for site-specific action. These medications include foams, lotions, creams, gels, ointments, and others. Topical drug delivery has various benefits such as site-specificity, better compliance, eliminating fluctuations in the levels of drugs, and improved suitability for self-medication.

Get Sample of this Report @ https://qualiketresearch.com/request-sample/Topical-Drug-Delivery-Market/request-sample

Regional Analysis

The Global Topical Drug Delivery Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

The Asia Pacific region is expected to grow at the highest CAGR during the forecast period. This is due to the increase of skin diseases like skin cancer, the growing use of contraceptives, and the increase in focus of pharmaceutical companies on the research and development of smart transdermal drug delivery systems, all of which are propelling adoption of topical drug delivery in the region. Also, the North America dominates the market due to the presence of large number of pharmaceutical companies & drug delivery technology providers in the region.

Key Players

Some key operating players are listed in this report such as Bausch Health Companies, Agile Therapeutics, Hisamitsu Pharmaceutical, Cipla, Almirall U.S., Cassiopea, Crescita Therapeutics Inc., 3M, MERCK & CO., Bayer AG, etc. Merger acquisition, partnership, and product launch are some key strategies adopted by the key players & sustain and capture the market share in the global topical drug delivery market. For instance, in December 2020, Agile Therapeutics, Inc. had launched its new Twirla (levonorgestrel and ethinyl estradiol) transdermal system which is a contraceptive patch.

Market Taxonomy

By Product type

· Formulations

Semisolid

Creams

Gels

Pastes

Ointments

Lotions

Liquid

Solutions

Suspensions

Solid

Suppositories

Powders

Devices

Transdermal Patches

Transdermal Gels

By Route of Administration

Skin

Ophthalmic

Rectal

Vaginal

Nasal

By End User

Home Care Settings

Hospitals & Private Clinics

Others

Get Details of Global Topical Drug Delivery Market @ https://qualiketresearch.com/reports-details/Topical-Drug-Delivery-Market

About Us

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

#Global Topical Drug Delivery Market Industry #Global Topical Drug Delivery Market Size

0 notes

healthcare-market · 3 years

Text

Controlled Release Drug Delivery Market Growth Analysis up to 2025

Controlled release drug delivery is a form of dosage that delivers medication or drug in predetermined manner. It is a system that provides continuous delivery of medication or drug in reproducible and predictable kinetics for predetermined time period throughout the course of gastrointestinal transit. It releases the drug until it reaches the specific region in the GI tract. Controlled release drug delivery systems employ drug-encapsulating devices from which medication or drug is released at controlled rate for long period of time, ranging from days to months. Controlled release drug delivery system has many benefits, such as, improved stability of drug, lower dose requirement, minimum side effects, improved drug safety and efficacy, enhanced patient compliance, and higher bioavailability. Rising awareness regarding the benefits associated with controlled release drug delivery systems over conventional drug delivery system are providing a fillip to the market. Furthermore, controlled release drug delivery system enables dose reduction which reduces the risk of overdose in elderly people. Unpleasant taste of pediatric medication or dysphagia for geriatric people further boosts the adoption of controlled release drug delivery system. However, complicated manufacturing process and stringent government regulations are likely to hamper the growth of the controlled release drug delivery market during forecast period.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54804

The global controlled release drug delivery market can be segmented based on technology, release mechanism, application, and geography. In terms of technology, the market can be divided into wurster technique, micro encapsulation, coacervation, transdermal, targeted delivery, and others. The targeted delivery segment is expected to hold significant share of the market as a large number of market participants has strong portfolio in the technology. Based on release mechanism, the controlled release drug delivery market can be segregated into micro reservoir feedback regulated, activation modulated, partition controlled, chemically activated systems, and polymer matrix systems. Based on application, the market can be classified into metered dose inhalers, injectables, oral controlled, drug eluting stents, transdermal, infusion pumps, and ocular patches. The oral controlled segment is expected to hold leading share of the global makret due to frequent use and wide availability of oral controlled release drug delivery system.

Request for Analysis of COVID19 Impact on Controlled Release Drug Delivery Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=54804

Based on geography, the global controlled release drug delivery market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global controlled release drug delivery market, followed by Europe. Key drivers of the market in these regions are rising research & development expenditure, presence of key market players, rising number of NDA and ANDA applications, growing patient pool with chronic diseases such as diabetes requiring prolong treatment, and growing demand for controlled relased medication. The controlled release drug delivery market in Asia Pacific is expected to grow rapidly during the forecast period due to high growth in population, growing geriatric population, and rapidly expanding pharmaceutical business in the region. Morover, increasing focus of key players for business expansion due to low manufacturing cost propels the growth of the controlled release drug delivery market in Asia Pacific.

Pre-Book Controlled Release Drug Delivery Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=54804&ltype=S

Major players operating in the global controlled release drug delivery market include Merck and Co., Inc., Johnson and Johnson, Alkermes plc, Coating Place, Inc., Aradigm Corporation, Corium International, Inc., Depomed, Inc., Orbis Biosciences, Inc. Pfizer, Inc, and Capsugel.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/increased-cases-of-gynecological-diseases-boost-demand-opportunities-for-players-in-gynecology-drugs-market-tmr-301155994.html

https://www.prnewswire.com/news-releases/remarkable-growth-in-working-women-population-worldwide-likely-to-fuel-breast-pumps-market-growth-tmr-301165675.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact:

Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com

0 notes

fostermarketarch · 3 years

Text

Drug-Device Combination Products Market Prominent Growth And Vendor Landscape By 2027

Drug device combination products are medical devices combined with a pharmaceutical ingredient that helps to deliver the drug to desired location in the patient’s body. They offer advantages like minimal side effects, controlled drug administration, improved patient compliance, and targeted drug delivery. Drug device combination products include inhalers, drug eluting stents, and wound care products and others. Owing to its wide range of advantages and increased sophistication, they have a lucrative market, which is expected to grow exponentially in the forecast period.

The drug-device combination products market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx drug-device combination products market.

Key Insights:

Latest Updates

Analyst Views

Future Outlook of the Market

Get Free PDF Brochure of this Report @https://www.fostermarketresearch.com/product/industry/7/41/Pdf%20Brochure/

Competitve Landscape:

Key players in the drug-device combination products market include: Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, Integer Holdings Corporation, Abbott Laboratories, Medtronic plc, Allergan, Inc., Alcon, Inc., Arrow International, Inc., Bausch & Lomb, Inc., Boston Scientific Corporation, ALK, SINOMED, Kaléo, Haselmeier, Flowonix Medical, Inc., CareFusion Corporation, Covidien PLC, and others.

The key players in drug-device combination products market are focused on developing products that adhere to regulatory guidelines and are innovative and futuristic. For instance, in October 2019, Becton, Dickinson and Company launched the BD Intevia 1mL two-step disposable auto-injector. Additionally, in October 2019, Haselmeier, has entered into a partnership agreement with Stevanato Group to develop, manufactured and supply the axis-D pen-injector for enabling advanced diabetes care. Adoption of cloud-based data management software in combination products is expected to offer lucrative growth opportunities for players in the global drug-device combination products market. For instance, in January 2020, Medtronic plc. launched Efficio, cloud-based data management software for use with the SynchroMed II intrathecal drug delivery system, for effective management of targeted drug delivery pump.

Market Taxonomy:

By Product Type

Drug-Eluting StentCoronary Drug-Eluting Stent Peripheral Drug-Eluting Stent

Infusion PumpImplantable Infusion Pump Insulin Infusion Pump Patient-Controlled Analgesia Pump Ambulatory Infusion Pump

Photodynamic therapy

Antimicrobial wound dressing

Prefilled SyringeSingle-Chamber Prefilled Syringe Dual-chamber Prefilled Syringe Customized Prefilled Syringe

Drug-Eluting BalloonCoronary Drug-Eluting Balloon Peripheral Drug-Eluting Balloon

Nebulizer

InhalerDrug Powder Inhaler (DPI) Metered Dose Inhaler (MDI) Soft Mist Inhaler (SMI)

Transdermal Delivery SystemPassive Delivery System Active Delivery System

Other Drug Device Combination Products

By Application

Cardiovascular

Diabetes

Cancer Treatment

Respiratory Ailment

Antimicrobial Treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Home Care

Others

For More Information of this Report @https://www.fostermarketresearch.com/product/industry/7/41/

Market Dynamics:

The drug device combination products market is primarily driven by the growing prevalence of chronic diseases such as diabetes, respiratory diseases, and cancer. For instance, in September 2019, the journal Diabetes Research and Clinical Practice estimated that 463 million people are suffering from diabetes globally in 2019 and the number is expected to reach 578 million by 2030 and 700 million by 2045. Apart from this, the increasing presence of regulatory healthcare authorities enforcing clearly defined protocols for premarket authorizations is anticipated to support manufacturers in gaining approvals for their products. For instance, in the European Union, the evaluation by a Notified Body of medical devices incorporating medicinal substances must include an opinion of a competent authority designated by an EU Member State, a process that can take more than 210 days (210 days + clocks stop) to complete. Additionally, the rising preference for minimally invasive surgeries (MIS) and growing deployment of portable devices that include, inhalers and nebulizers are some key factors that boost market growth.

However, stringent regulatory policies, product recalls and complications associated with some of the drug device combinations are expected to hamper the market. For instance, in December 2019, Medtronic Recalls SynchroMed II Implantable Drug Infusion Pump due to the Potential Presence of Foreign Particles Inside the Pump Motor Assembly Which May Lead to a Pump Motor Stall

Benefits You Gain With Our Research Methodology:

Develop your Business strategies to refine the profits in near team.

Grow your Business profit ratio through our analytics report.

Acquire the valuable insights on different products, services and technology along with their obsolescence nature in the foreseen period.

Gain and upper hand on competition by having competitive financial, growth and economic data.

Identity future threats by our accurate forecasting strategies.

Obtain Go-To market strategy to increase your chances in the existing market.

Buy Now This Business Strategic Report to Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/7/41/

About Foster Market Research:

Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data.

Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience.

1701 Royal Lane, #1306, Dallas Tx-75229 Phone: +1 469 4981929 Email: [email protected]

0 notes

awesomechrisharry · 3 years

Text

Oral Thin Film Drug Delivery & Manufacturing Market SWOT Analysis by Top Trends | 2020-2026

The Oral Thin Film Drug Delivery & Manufacturing market report offers detailed explaination on different Leading level industries which are functioning in global regions. Additionally, it gives detailed elaboration on different government rules, policies, and plans to recognize the overall scope of the Market. The Oral Thin Film Drug Delivery & Manufacturing market was developed with a primary focus on the competitive sphere, retail, geographical expansion and market dynamics, including drivers, constraints and opportunities. In this report, various chapters deliver a logical understanding of the market scenarios with relevant examples. This report also analyze the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

To Know More Details About This Report, Get Sample @ http://www.empiricaldatainsights.com/sample-request/13367

The objective of this examine is to determine market sizes for various sectors and countries in recent years and predict values for the next six years. The report is created to integrate the qualitative and quantitative aspects of the industry both in the regions and in the countries participating in the study. In addition, the report also provides detailed information on key aspects, such as the drivers and challenges that will determine future market growth. In addition, the report should also incorporate opportunities in small markets for interested parties to invest together with a detailed analysis of the competitive landscape and product offerings of key stakeholders.

Major Market Players Covered In This Report:

Pfizer, Allergan, Indivior, Solvay, ZIM Laboratories, MonoSol Rx Allergan, Sumitomo Dainippon Pharma, IntelGenx, Novartis, NAL Pharma, Wolters Kluwer

Acquisition, effective mergers and ongoing technological innovations are some of the strategies adopted by leading manufacturers. The launch of new products is also one of the key strategies adopted by the key players.

Feel Free To Make an Enquiry Or Customization of This Report @ http://www.empiricaldatainsights.com/enquire-before/13367

The specified segments and sub-sections of the market are explained below:

By Product Type:

Oral Thin Film, Transdermal Thin Film, Others (Ocular Thin Film, etc.)

By Application/End-user:

Hospital Pharmacies, Drug Stores, Retail Pharmacies, E- Commerce

Oral Thin Film Drug Delivery & Manufacturing Market Trends To 2026

Regions Covered from the Worldwide Oral Thin Film Drug Delivery & Manufacturing Market:

North America (the U.S., Canada)

Latin America (Brazil, Mexico, Argentina and other countries)

Asia Pacific (India, Japan, China, Australia and New Zealand and other countries)

Europe (Germany, France, the U.K., Spain, Italy, Russia, and other countries)

Middle East and Africa (GCC, South Africa, Israel and Other countries)

Order This Report Now @ https://www.empiricaldatainsights.com/buy-now/13367/?price=su

Reasons to Purchase this Report:

Trend estimates in the development of the 2020-2026 Oral Thin Film Drug Delivery & Manufacturing market with recent trends and SWOT analysis

Scenario of market dynamics, along with opportunities for market growth in the coming years.

Market segmentation analysis, including qualitative and quantitative research that includes the impact of economic and political aspects.

Regional and national analysis that combines demand and supply forces that influence market growth.

Market value (US $ millions) and volume data (millions of units) for each segment and segment

A competitive landscape that includes the market share of key players, along with new projects and strategies adopted by players in the last six years.

About Us

An optimally formulated blueprint is the main essence of a successful business. To prepare a similar blueprint - accurate and well-informed data is required to make simplified decisions. We at Empirical Data Insights assimilate the same quality of data through our discreetly prepared market reports. Providing the right data to businesses and cater to the process of decision making or capturing markets, is what we aim to do. Our reports will prove to be useful in each & every step of the chain and business process.

http://www.empiricaldatainsights.com/

([email protected])

#Oral Thin Film Drug Delivery & Manufacturing Market #Oral Thin Film Drug Delivery & Manufacturing Market 2021

0 notes

market-research-future · 3 years

Text

Controlled Release Drug Delivery Market Analysis, Landscape and Growth Prospects

Global Controlled Release Drug Delivery Market Research Report, by Route of administration (Transdermal, Oral), Release Mechanism (Polymer-based, Micro reservoir Partition), Products (Metered Dose Inhalers), End User (Hospital)— Forecast till 2023

The controlled release drug delivery market is growing rapidly over the past few years. Increasing prevalence of chronic diseases and increasing government regulation to prevent overdose effects act as a significant driving force pushing up the market growth. Furthermore, the growing geriatric and pediatric population is creating huge market demand. Moreover, the advantages that these controlled release drug delivery systems offer accelerate the growth of the market.

Latest Free Sample PDF Available @ https://www.marketresearchfuture.com/sample_request/6794

According to Market Research Future (MRFR), the global Controlled Release Drug Delivery Market is expected to create a valuation of over USD 70.15 BN by 2023, growing at a double-digit CAGR of 14 % during the review period (2018 – 2023). Technological advancements, improved outcomes & patients’ experience, beneficial reimbursement policies, and increasing awareness towards healthcare are other key factors impacting the market growth, positively.

On the other hand, some limitations associated with the application of these systems, such as the possibility of less accuracy in adjusting the dosage and controlled release drug delivery system is not suitable for all drugs are expected to impede the growth of the market. Also, the higher cost of these systems compared to the conventional drug delivery systems hampers the growth of the market.

Global Controlled Release Drug Delivery Market – Segmentation

The report is segmented into five main dynamics to widen the scope of understanding,

By Route of Administration: Oral, Injectable, Ocular, Nasal, Topical, Implantable, and Transdermal, others.

By Release Mechanism: Micro-Reservoir Partition-controlled Drug Delivery Systems, Polymer-based Drug Delivery Systems, Feedback-Regulated Drug Delivery Systems, Chemically Activated Controlled Drug Delivery Systems, and Activation Modulated Drug Delivery Systems.

By Products: Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug-Eluting Stents, Sustained Release, and Ocular Implants.

By End-user: Hospital & Clinics, Personal Use, Research Centers, and others.

By Regions: Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World

Global Controlled Release Drug Delivery Market – Geographical Analysis

North America is the leading market for controlled release drug delivery. The significant market share of the market attributes to the vast patient pool suffering from various diseases, mainly such as gastrointestinal disorders (Crohn’s disease and ulcerative colitis) and Alzheimer’s, etc. Besides, advanced healthcare infrastructure, growing pharmaceutical industry, and increasing research & development activities foster the regional market growth.

North America is a well-developed region, and its highest GDP helps the region to have the edge over other regions in terms of aspects such as healthcare and technology. Additionally, the presence of the geriatric population and development in medical technology are supporting the growth of the market. Indeed, the high economic growth is a key driving force behind the growth of the regional market, allowing access to the quality of life for the people.

Europe stands second in the global controlled release drug delivery market. The increasing prevalence of respiratory diseases and high blood pressure or hypertension among the population boosts the growth of the regional market. The well-established healthcare sector is a major growth impeding factor for market growth in the region. Moreover, the resurging economy is playing a vital role in market development, allowing the proliferation of the healthcare sector in the region.

Germany contributes to the growth of the regional market, hugely due to its flourishing medical devices markets. Furthermore, the UK and France, with the increasing investments in controlled release drug delivery, drive the regional market at a large scale. The European controlled release drug delivery market is estimated to register a phenomenal CAGR during the review period.

The Asia Pacific controlled release drug delivery market is growing rapidly owing to the huge patient population suffering from chronic diseases and an increase in the geriatric and pediatric population. Also, the increasing demand for controlled doses to reduce the side effects and toxicity level in the patients contribute to the market growth of controlled release drug in Asia Pacific countries.

The rising economy in countries such as China, Japan, South Korea, and India impacts market growth positively. Furthermore, the rising demand for quality devices in healthcare and rapidly developing healthcare technology is expected to foster the APAC controlled release drug delivery market.

Global Controlled Release Drug Delivery Market – Competitive Landscape

The global controlled release drug delivery market appears to be fiercely competitive and fragmented, with many well-established players forming a competitive landscape. Brand reinforcement, mergers & acquisitions, and innovation remain the popular trends for the key players in the market.

Major Players:

Players leading the controlled release drug delivery market include Coating Place, Inc.(US), Depomed, Inc. (US), Corium International Inc.(US), Pfizer Inc.(US), Alza Corporation (Johnson & Johnson)(US), SKY Pharmaceuticals Pvt. Ltd.(China), Biogen (US), AstraZeneca (US), GlaxoSmithKline (UK), Collegium Pharmaceutical (US), Novartis (UK), and Allergan(Ireland), among others.

Industry/ Innovation/ Related News:

December 12, 2019 —- The 3M Company (the US), a multinational conglomerate corporation operating in the fields of industry, worker safety, health care, and consumer goods, announced that it has agreed to sell most of its drug-delivery business to an affiliate of Altaris Capital Partners (the US), an investment firm focused on the healthcare industry. The deal is finalized at approximately USD 650 MN.

3M’s drug delivery business is a leading provider of transdermal and inhalation delivery technologies. This transaction would allow 3M to focus more on its core health care business and retain a share in the drug delivery business as it grows over the coming years.

However, 3M will retain its transdermal drug delivery components business. 3M is also looking for pharmaceutical partners for the development of a smart inhaler, the project it has already undertaken.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/controlled-release-drug-delivery-market-6794

Brows More Healthcare Related Research Reports:

Irritable Bowel Syndrome Treatment Market Analysis, Growth Values and Forecast to 2023

Voice Prosthesis Devices Market | Share, Technology and Forecast To 2023

Oxygen Therapy Equipment Market by Product, Portability, Applications and Global Forecast to 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

0 notes

gojennybaker · 3 years

Text

Global Pharmaceutical Packaging Market 2021 Business Growth by Size and Latest Scope, Top Players | Impact of COVID-19 on Global Industry, Regional Opportunities Forecast to 2025

Researching the Pharmaceutical Packaging Market report provides comprehensive knowledge and valuable insight into current market prospects and emerging growth scenarios. The Pharmaceutical Packaging Market Report focuses on market participants as well as new market entrants. In short, this report includes all the insights you need about global Pharmaceutical Packaging markets such as cost / volume data, marketing strategies, and expert opinion. The market is projected to reach nearly USD 155 billion by the end of 2025

Get a Sample Copy of This Report @ https://www.adroitmarketresearch.com/contacts/request-sample/358

Pharmaceutical Packaging Market Report provides detailed analysis of global market size, regional and national market size, segment growth, market share, competitive landscape, sales analysis, impact on domestic and global players, value chain optimization, trade rules, recent developments, opportunity analysis, strategic analysis of market growth, new product launches and technological innovation.

The report has analyzed several players in the market, some of which include: Amcor PLC, Gerresheimer AG, Berry global Inc., Schott AG, Aptargroup, Inc., Becton, Dickinson and company, Catalent, Inc., Nipro Corporation, West Pharmaceutical Services, Inc., Westrock Company

The prominent players in the market are categorized by price, quality, brand, product differentiation, and product portfolio. They focus on innovation in manufacturing technology to improve the efficiency and shelf life of products and services.

The Pharmaceutical Packaging Market report contains many descriptions of market segmentation by product type and application, and provides a descriptive framework for trends and constraints across different segments and sub-segments.

Key segments across Pharmaceutical Packaging market

Type Overview, 2018-2025, (USD Billion)

Material Overview, 2018-2025, (USD Billion)

Mode Overview, 2018-2025, (USD Billion)

Regional Overview, 2018-2025, (USD Billion)

Plastic bottles

Blister packs

Labels & accessories

Caps & closures

Medical specialty bags

Pre-filled syringes

Temperature-controlled packaging

Pouches & strip packs

Ampoules

Vials

Pre-filled inhalers

Medication tubes

Jars & canisters

Cartridges

Others

Plastics & polymers

Paper & paperboards

Glass

Metals

Others

Oral drug delivery packaging

Pulmonary drug delivery packaging

Transdermal drug delivery packaging

Injectable packaging

Topical drug delivery packaging

Nasal drug delivery packaging

Ocular drug delivery packaging

IV drugs delivery packaging

Other

North America

Europe

Asia Pacific

Central & South America

Middle East & Africa

U.S.

Canada

Mexico

Germany

France

Rest of Europe

China

India

Japan

Rest of Asia-Pacific

Brazil

Argentina

Saudi Arabia

The report presents the market size with 2018 as the base year under review and the annual forecast to 2026 in terms of revenue (in millions of US dollars). Our analysts have implemented a combination of top-down and bottom-up approaches to market sizing, key regional markets, dynamics and trends for different types and applications.

Browse the complete report @ https://www.adroitmarketresearch.com/industry-reports/pharmaceutical-packaging-market

Scope of Market

Pharmaceutical Packaging Market Report helps you make informed business decisions with complete understanding and in-depth analysis of market segments.

It provides accurate analysis of the changing dynamics of competition and allows you to stay ahead of the competition.

Analysis of the many growth opportunities in the Pharmaceutical Packaging industry for stakeholders and a detailed description of the competitive landscape for high-level players.

Key points related to market targeting Pharmaceutical Packagings such as product definition, application range, revenue statistics, supply and demand statistics.

Growth of the global Pharmaceutical Packaging market in various regions such as North America, Europe, Asia Pacific, South America, the Middle East and Africa.

Competitive analysis of the main competitors in the market, as well as analysis of the latest trends and business strategies used by various companies.

Market research also provides a comprehensive analysis of the global Pharmaceutical Packaging market, including all industry stakeholders. Internal and external factors that influence the industry, both positively and negatively, have been carefully analyzed, which will provide a futuristic view of the market for decision makers.

Reasons why you should buy this report:

• Understand the present and future of the application Pharmaceutical Packaging market in both developed and emerging markets.

• The report helps realign business strategies by highlighting business priorities by Pharmaceutical Packagings.

• The report sheds light on the segment that is expected to dominate the industry and the Pharmaceutical Packaging market.

• Predicts regions waiting to climb.

• Latest developments in the Pharmaceutical Packaging industry and insights from industry leaders as well as their market shares and methods.

• Save time on entry-level research as the report provides important insights into growth, size, leading players and industry segments.

• Save and cut time by conducting entry-level research showing growth, size, leading players and global market segments.

If You Have Any Query, Ask Our Experts @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/358

About Us :

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market's size, key trends, participants and future outlook of an industry. We intend to become our clients' knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code - Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Ryan Johnson Account Manager Global 3131 McKinney Ave Ste 600, Dallas, TX75204, U.S.A. Phone No.: USA: +1 972-362 -8199/ +91 9665341414

0 notes

researchvishal · 2 years

Text

Peptide Therapeutics Market Revenue, Worth, Size, Segment by Type, Application, Key Companies | FMI

Peptide therapeutics are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such as cancer, cardiovascular diseases, hematologic diseases, and gastro-intestinal diseases.

The global peptide therapeutics market was valued at US$ 25.6 Bn in 2021, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2022-2025).

Key Takeaways of Peptide Therapeutics Market Study

Various peptide therapeutics are patented, and, in the mid of this decade, a majority of these patents are expected to reach their expiry dates, leading to higher generic competition.

Parenteral route continues to hold the leading revenue share in the peptide therapeutics market, owing to effective drug delivery and higher therapeutic index.

Key Players Focus on Strategic Collaborations and Generic Launches to Widen Regional Presence

Leading players in the peptide therapeutics market, such as AstraZeneca plc, Merck Co. & Inc., and Elli Lily, are concentrating on business expansions through joint ventures and distribution agreements, and are capturing untapped market potential.

Additionally, market incumbents are entering into collaborations in order to expand their regional presence and manufacturing capabilities in the global peptide therapeutics market.

More Valuable Insights on Peptide Therapeutics Market

Key Segments Of Peptide Therapeutics Market Industry Survey

By Application :

Cancer

Cardiovascular Diseases

Central Nervous Systems

Metabolic Disorders

Infections

Hematological Disorders

Gastrointestinal Disorders

Dermatology

Respiratory Disorders

Acromegaly

Other Applications

By Route of Administration :

Parenteral Route of Administration

Mucosal Route of Administration

Oral Route of Administration

Transdermal of Route Administration

By Drug Type :

Branded Drugs

Generic/Biosimilar Drugs

By Region :

North America Peptide Therapeutics Market

Latin America Peptide Therapeutics Market

Europe Peptide Therapeutics Market

East Asia Peptide Therapeutics Market

South Asia & Pacific Peptide Therapeutics Market

Middle East & Africa (MEA) Peptide Therapeutics Market

For more Information @ https://www.futuremarketinsights.com/reports/peptide-therapeutics-market

0 notes

gomarcuskel12 · 3 years

Text

Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin (2020-2026) which would mention How the Covid-19 is Affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Key Regions and Proposal for Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin Players to battle Covid-19 Impact.

Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin (2020-2026)

The Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin (2020-2026) report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of Global Market. It offers detailed research and analysis of key aspects of the Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin.

Major Players covered in the Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin report : Endo International GlaxoSmithKline Mylan ALLERGAN Hisamitsu Pharmaceutical Pfizer and More...

Get PDF Sample Report With Impact of COVID-19 on Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin@ https://www.mraccuracyreports.com/marketreports/7/184963/Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

The report offers clear guidelines for players to cement a position of strength in the global Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin. It prepares them to face future challenges and take advantage of lucrative opportunities by providing a broad analysis of market conditions. the global Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin will showcase a steady CAGR in the forecast year 2020 to 2026.

Major Type: Transdermal Absorption Sonophoresis Iontophoresis Microneedle Transdermal Delivery

Application Segments: Hospital Pharmacies Online Pharmacies Independent Pharmacies & Drug Stores

Our Complimentary Sample Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology.

Inquire and Get Up to 30% Discount By Clicking Here! https://www.mraccuracyreports.com/marketreports/7/184963/Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Regions Covered in the Global Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin:• The Middle East and Africa (GCC Countries and Egypt)• North America (the United States, Mexico, and Canada)• South America (Brazil etc.)• Europe (Turkey, Germany, Russia UK, Italy, France, etc.)• Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin Size:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year: (2020-2026)

Highlights of the Report: • Accurate market size and CAGR forecasts for the period 2019-2026• Identification and in-depth assessment of growth opportunities in key segments and regions• Detailed company profiling of top players of the global Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin• Exhaustive research on innovation and other trends of the global Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin• Reliable industry value chain and supply chain analysis• Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects

For Free Download Report: https://www.mraccuracyreports.com/request/download/7/184963/Post-pandemic Era-Global Capsaicin Patches Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Reasons to buy:

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying Top Manufacturer.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.

Report will be updated with the latest data and delivered to you within 1-2 working days of order.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis.

Create regional and country strategies on the basis of local data and analysis.

Customization of the Report:

MR Accuracy Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Contact Us: Mr. Marcus Kel Call: +1 804 500 1224 / +44 741841 3666 (International) +91 7184963728100 (ASIA) Email: [email protected] Website: www.mraccuracyreports.com

ABOUT US

MR ACCURACY REPORTS offers numerous market related consulting services, syndicated research reports and custom - made research reports. MR Accuracy Reports is a Market Research and consulting company that accomplishes requirement of research agencies, small, medium and large corporations, global business leaders, government organizations, SME’s, Individual & Start - ups, top management consulting firms. MRA Reports also offers customized research reports, consulting services, and syndicated research reports.We delivers strategic market research reports, statistical survey, SWOT, PESTLE, crucial facts, employee details, industry analysis &forecast data on products & services, markets and companies. We support in business decision making on features such as market entry strategies, market sizing, market share analysis, sales & revenue, technology trends, competitive analysis, product portfolio &application analysis etc. Our library of 750,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy & Power, Manufacturing, Automotive & Transportation, Food & Beverages etc.

WHY CHOOSE US

We work with international clients - As of now we have worked with clients in 70 countries.Our viewpoint means we know what is trendy in your regional market and other parts of the globe. An efficient strategy is an object that encouragements a business to stand out of the box.MRA Reports is the new initiation in the industry that will provide you with the lead your business requirements. MRA Reports is the best endpoint for your business intelligence since our qualitative & quantitative sources of information are capable to give one - stop resolutions.We resourcefully combine qualitative and quantitative research in precise percentages to have the finest report and also help you to grow.

USEFUL INFORMATION OF MRA REPORTS

We have functioned with companies just like yours - MRA Reports has the benefit of having concluded plentiful consulting projects across industries.This proves there are 99 % chances we already have expertise, which you are looking for. "

#Post-pandemic Era-Global Capsaicin Patches Market #Post-pandemic Era-Global Capsaicin Patches Forecast #Post-pandemic Era-Global Capsaicin Patches Industry Trends #Post-pandemic Era-Global Capsaicin Patches Market Share #Post-pandemic Era-Global Capsaicin Patches Market Growth #Post-pandemic Era-Global Capsaicin Patches Industry Size #Post-pandemic Era-Global Capsaicin Patches Market Overview mraccuracyreports

0 notes

nitasonwane · 3 years

Text

Thin Film Drugs Market Growth, Top Key Players, Trend, Opportunities Forecast to 2027

please visit: https://www.fortunebusinessinsights.com/thin-film-drugs-market-104883

Rising Focus on Developing COVID-19 Vaccine to Impact Growth Negatively

Retail Pharmacy Segment to Dominate Backed by Easy Availability of Drugs

0 notes

pharmaphorumuk · 5 years

Text

SMi Presents the 2nd Annual Conference: Injectable Drug Delivery 2019

Assessing the innovations in formulations and devices for enhanced injectable delivery

The SMi Group is pleased to announce the second annual Injectable Drug Delivery conference which will be held in London on the 15th and 16th May 2019.

The global injectable drug delivery market is expected to grow from $400 billion to $1200 billion by 2046 with a CAGR of 12.8%.

Injectable drug delivery is a method of drug administration into the body with a needle via various routes including intramuscular and intravenous. These are examples of conventional drug delivery. Recently, there has been a focus on novel drug delivery, including needle-free injectors, and transdermal patches. Long acting injectables (LAI) are developing fast as a push towards patient centric devices drives the industry. Habitually, injectables were used for delivery of hormones, vaccines and insulin but as technology advances the application is continuing to expand. Now there is an emphasis on finding solutions to chronic conditions and the biological drugs required involve formulation development challenges for proteins, including high viscosity and high volume. Self-administrative, connected, and ergonomic devices are the new drive. Self-injectable devices include pen injectors for diabetic patients. The wealth of expansion available in the field of connected devices is huge. The regulatory landscape is challenging as it evolves rapidly with the market demand for new devices.

The benefits of attending:

Developing on last year’s success, this event assembles an international audience to include regulatory, device design, packaging and formulation professionals. The devices need to be designed for the new generation of drugs and they need to provide safety with a strong patient focus. This event is will help inspire you to help drive this industry forward and learn about the predicted market trends, critical digital and chemical developments and the push for patient compliance in a changing regulatory landscape.

This conference offers a chance to learn about innovative injectable drug delivery systems with industrial insights on the following:

– Life cycle management for developing devices that are both user friendly and revenue effective

– Device design considerations

– Long acting injectables and bringing these therapeutics to market with case studies

– Connected devices, GDPR and cyber security programs

– Developments in primary packaging

– Growth in transdermal delivery and subcutaneous infusion devices

– Digital health partnerships

– Large volume patch pump innovation examples

Who should attend

Executives, Directors, VPs, Heads, Principals, Managers, Scientists, Researchers of:

Autoinjectors

Wearables

Device Engineering

Human Factors

CMC

Injectables

Sterile Manufacturing

Packaging

Regulatory Affairs

Featured Speakers:

Bjorg K. Hunter, Device Engineering Manager, GSK

Miranda Newbery, Human Factors Consultant, Inspired Usability

Blake Green, Regulatory Affairs Senior Manager, Devices, Amgen

Quentin Le Masne, Head of Engineering team – Electro-Medical / Drug Delivery Devices, Merck

Vasco Filipe, Formulation and Drug Process Development Section Head for Biologics, Sanofi

Stephen Paboojian, Senior Project Leader I for Device Development, Novartis

Tom Lawrie-Fussey, Digital Services Specialist, Cambridge Design Partnership

Terry Reed, Director of Business development, AstraZeneca

Joel Richard, Head of Technical and Pharmaceutical Operations, MedinCell

*Plus, pre-conference workshops – 14th May 2019

EARLY-BIRD RATES:

BOOK BY 31st JANUARY AND SAVE £400

BOOK BY 28th FEBRUARY AND SAVE £200

BOOK BY 29th MARCH AND SAVE £100

Additional Contact Info:

T: +44 (0)20 7827 6088

E: [email protected]

LinkedIn: @SMi Pharma

Twitter: @SMiPharm #SMi

The post SMi Presents the 2nd Annual Conference: Injectable Drug Delivery 2019 appeared first on Pharmaphorum.

from Pharmaphorum https://pharmaphorum.com/events/smi-presents-the-2nd-annual-conference-injectable-drug-delivery-2019/

0 notes